Document Detail


How should patients treated with alpha-blockers be followed? Insights from an ambulatory blood pressure monitoring database.
MedLine Citation:
PMID:  16612247     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Adrenergic alpha-antagonists have been suggested to confer lesser protection, compared to diuretics, when used as first agents for hypertension. While differences in clinic blood pressure may be partly responsible, this inferiority is unexpected in light of the metabolic advantages of alpha-blockade. The aim of this study was to evaluate the relationship between use of alpha-blockers and blood pressure dipping. METHODS: A database of a 24-h ambulatory monitoring service was cross-sectionally evaluated for associations between antihypertensives and dipping. There were 681 treated subjects during a 3-year period (age 63 +/- 14, 57% female). RESULTS: Overall, 78 of 681 treated hypertensive subjects used alpha-blockers (11%). Nine per cent of dippers and 16% of nondippers were treated with alpha-blockade, odds ratio 2.0. Whereas clinic, 24-h, and awake blood pressures were similar in alpha-blocker users and nonusers, sleep blood pressure was significantly higher in the former group. Furthermore, significantly fewer subjects given alpha-blockers had a controlled sleep blood pressure. Among alpha-blocker nonusers sleep blood pressure was the best controlled category, whereas in alpha-blocker users manual blood pressure had the highest rate of control. Generally, accounting for covariates of alpha-blockade (age, gender, diabetes, total number of medications) did not influence the above-mentioned trends. Finally, a limited negative dose-response relationship between alpha-blockade and dipping magnitude was also noticed. CONCLUSIONS: We found a significant negative association between adrenergic alpha-blockade and the magnitude of sleep-related blood pressure decline. Awaiting results from interventional studies, this may suggest a need to perform ambulatory monitoring in patients given alpha-blocking agents (or at least supine and standing measurements), and may partially clarify the inferiority of doxazosin in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Authors:
Iddo Z Ben-Dov; Liora Ben-Arie; Judith Mekler; Michael Bursztyn
Related Documents :
18514937 - Association of the fourth heart sound with increased left ventricular end-diastolic sti...
25415777 - Comparative efficacy of levobupivacaine and ropivacaine for epidural block in outpatien...
236167 - Timolol: a preliminary report of its pharmacological properties and therapeutic efficac...
2547867 - Adrenoceptors on blood cells in patients with essential hypertension before and after m...
23421577 - Solution structure of the q41n variant of ubiquitin as a model for the alternatively fo...
1768817 - Left ventricular end-systolic pressure estimated from measurements in a peripheral artery.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of hypertension     Volume:  24     ISSN:  0263-6352     ISO Abbreviation:  J. Hypertens.     Publication Date:  2006 May 
Date Detail:
Created Date:  2006-04-13     Completed Date:  2006-11-02     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8306882     Medline TA:  J Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  861-5     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Hadassah - Hebrew University Medical Center, Mount-Scopus Campus, Jerusalem 91240, Israel. vp02292@netvision.net.il
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-Antagonists / therapeutic use*
Aged
Blood Pressure / drug effects*
Blood Pressure Monitoring, Ambulatory*
Circadian Rhythm / drug effects
Cross-Sectional Studies
Databases, Factual*
Dose-Response Relationship, Drug
Female
Humans
Hypertension / drug therapy*
Male
Middle Aged
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Antagonists

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women.
Next Document:  Lack of prognostic role of endothelial dysfunction in subcutaneous small resistance arteries of hype...